Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (Weighted Average) (2022 - 2026)
Cannabis Bioscience International Holdings' Shares Outstanding (Weighted Average) history spans 5 years, with the latest figure at $11.6 billion for Q1 2026.
- On a quarterly basis, Shares Outstanding (Weighted Average) rose 8.39% to $11.6 billion in Q1 2026 year-over-year; TTM through Feb 2026 was $11.6 billion, a 8.39% increase, with the full-year FY2025 number at $10.7 billion, up 3.86% from a year prior.
- Shares Outstanding (Weighted Average) hit $11.6 billion in Q1 2026 for Cannabis Bioscience International Holdings, roughly flat from $11.6 billion in the prior quarter.
- Over the last five years, Shares Outstanding (Weighted Average) for CBIH hit a ceiling of $11.6 billion in Q3 2025 and a floor of $8.1 billion in Q4 2022.
- Historically, Shares Outstanding (Weighted Average) has averaged $10.3 billion across 5 years, with a median of $10.4 billion in 2023.
- Biggest five-year swings in Shares Outstanding (Weighted Average): grew 27.7% in 2023 and later increased 1.23% in 2024.
- Tracing CBIH's Shares Outstanding (Weighted Average) over 5 years: stood at $8.1 billion in 2022, then grew by 27.7% to $10.3 billion in 2023, then increased by 1.6% to $10.5 billion in 2024, then increased by 10.76% to $11.6 billion in 2025, then changed by 0.0% to $11.6 billion in 2026.
- Business Quant data shows Shares Outstanding (Weighted Average) for CBIH at $11.6 billion in Q1 2026, $11.6 billion in Q4 2025, and $11.6 billion in Q3 2025.